NCT06967961
- Conditions
- Adenocarcinoma of Endometrium, Carcinoma, Carcinoma, Transitional Cell, +41 more
- Locations
-
- Oncopole Claudius Regaud, IUCT-O Toulouse, France
Clinical trial condition
Nonseminomatous germ cell tumor
Explore clinical trials studying Nonseminomatous germ cell tumor. Study availability and eligibility vary by location and protocol.
12 public trials
5 recruiting studies
Nonseminomatous germ cell tumor trial results
NCT04804007
- Conditions
- Germ Cell Tumor, Neoplasms, Neoplasms by Histologic Type, +4 more
- Locations
-
- Indiana University Melvin & Bren Simon Cancer Center Indianapolis, Indiana, United States
NCT06133543
- Conditions
- Germ Cell Tumor, Germinoma, Neoplasms, +5 more
- Locations
-
- University Hospital of Duesseldorf Düsseldorf, Germany
NCT06418789
- Conditions
- Adenocarcinoma, Carcinoma, Choriocarcinoma, +16 more
- Locations
-
- National Medical Research Center of Oncology named after N.N.Petrov Ministry of health of Russia Saint Petersburg, Russian Federation, Russia
NCT05705687
- Conditions
- Non-Seminomatous Germ Cell Tumor, Nonseminomatous germ cell tumor
- Locations
-
- Gustave Roussy Villejuif, France
Active, not recruiting
Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors
NCT02375204
- Conditions
- Adenocarcinoma, Carcinoma, Childhood Teratoma, +22 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- Loma Linda University Medical Center Loma Linda, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
Active, not recruiting
Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors
NCT03158064
- Conditions
- Dysgerminoma, Germ Cell Tumor, Germinoma, +8 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
- Memorial Sloan Kettering Commack Commack, New York, United States
Active, not recruiting
A Phase II Trial of Cabozantinib With Patients With Refractory GCTs
NCT04876456
- Conditions
- Germ Cell Tumor, Germinoma, Neoplasms, +6 more
- Locations
-
- Indiana University Melvin & Bren Simon Cancer Center Indianapolis, Indiana, United States
Completed
CD30 CAR for CD30+ NSGCT
NCT05634785
- Conditions
- Germ Cell Tumor, Neoplasms, Neoplasms by Histologic Type, +3 more
- Locations
-
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill Chapel Hill, North Carolina, United States
NCT02115165
- Conditions
- Non-seminomatous Germ-cell Tumors, Nonseminomatous germ cell tumor
- Locations
-
- Gustave Roussy Cancer Campus Grand Paris Villejuif, Val de Marne, France